CE Approval for Medinol’s EluNIR-PERL™ Drug-Eluting Stent System

May 23, 2024

We are thrilled to announce that our innovative EluNIR-PERL™ DES has received CE approval! This marks a significant milestone in our commitment to advancing cardiovascular care and offering pioneering solutions to patients worldwide.

The EluNIR-PERL™ DES is designed to enhance procedural precision and improve patient outcomes, building upon the proven performance of the EluNIR™ DES system. With unique features such as four radiopaque markers and a hybrid polymer-metal radiopaque catheter tip, the EluNIR-PERL™ ensures outstanding visualization during PCI procedures.

This achievement reflects our dedication to excellence and innovation in medical device technology. We are proud to provide physicians with tools that not only meet but exceed the demands of modern interventional cardiology.

Accessibility Toolbar